Scinovex
Subscribe
T

Torsten O. Nielsen

BC Cancer AgencyORCID https://orcid.org/0000-0003-3769-2517
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—

Top Publications

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Journal of Clinical Oncology20094,815 citations
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
JAMA20063,808 citations
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Annals of Oncology20143,065 citations
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
Clinical Cancer Research20042,652 citationsFirst authorCorresponding
Metastatic Behavior of Breast Cancer Subtypes
Journal of Clinical Oncology20102,247 citations
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
JNCI Journal of the National Cancer Institute20092,199 citations
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
JNCI Journal of the National Cancer Institute20111,975 citations
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
Clinical Cancer Research20081,187 citations
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
PLoS Medicine20101,150 citations
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Clinical Cancer Research2010818 citationsFirst authorCorresponding
Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival
Science Translational Medicine2011786 citations
The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status
American Journal Of Pathology2004658 citations
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
BMC Cancer2007367 citations
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
BMC Cancer2014304 citationsFirst authorCorresponding
Torsten O. Nielsen · Scinovex